BU-NOT-SET

CONTACT US
A CDMO’s insight into the pharma M&A landscape
  • Industry trends
Eyes
Insight
Recipharm’s continuous global support throughout the COVID-19 pandemic
  • Industry trends
Eyes
Insight
Is outsourcing the most viable pathway for innovators?
  • Manufacturing
Meeting
Insight
Developing a generic prolonged-release isosorbide-5-mononitrate tablet
  • Drug product
Two lab workers
Case study
Recipharm Wins two 2020 CMO Leadership Awards
  • Industry trends
Eyes
Insight
Recipharm’s global teams support and engage with their local communities in the fight against COVID-19
  • Corporate
Eyes
Insight
Recipharm launches new virtual inspection and audit tool for customers, in light of COVID-19 outbreak
  • Manufacturing
Eyes
Insight
Recipharm 25 years
  • Corporate
24 years
Brochure
API product list
  • Drug substance
white pills
Fact sheet
Case study
  • Drug product
Modified release fixed dose combination product with two poorly soluble drug substances
Insight
  • Drug product
Patient centricity during drug development and commercialisation
Insight
  • Drug product
10 considerations to kick-start your drug development journey
Insight
  • Drug product
Guidance for start-ups on drug development
White paper
  • Drug product
  • Drug substance
Drug development for start-ups
Insight
  • Sustainability
Optimising environmental sustainability
Insight
  • Industry trends
Adapting to deal with the COVID-19 pandemic
Insight
  • Sustainability
On Drug Delivery – Sustainability Q&A
Insight
  • Analytical chemistry
Optimising analytical chemistry to improve speed to market